Related Experiment Video
Updated: Jul 31, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Management of bacterial endocarditis.
B E Giessel1, C J Koenig, R L Blake
1University of Missouri-Columbia School of Medicine, USA.
Antibiotic selection for bacterial endocarditis depends on the pathogen, valve type, and patient factors. Treatment guidelines, such as those from the American Heart Association, help determine effective antimicrobial strategies for various infections.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Bacterial endocarditis commonly involves viridans streptococci, enterococci, and staphylococci.
- Treatment decisions are guided by pathogen identification, antibiotic susceptibility, valve status (native or prosthetic), and patient allergies.
Purpose of the Study:
- To outline current antibiotic therapy recommendations for bacterial endocarditis.
- To provide guidance based on American Heart Association guidelines.
Main Methods:
- Review of established treatment protocols for bacterial endocarditis.
- Categorization of therapies based on causative organisms (streptococci, enterococci, staphylococci) and valve type.
Main Results:
- Penicillin or ceftriaxone for streptococcal infections.
- Penicillin/ampicillin plus gentamicin for susceptible enterococci; vancomycin for penicillin-resistant strains.
- Nafcillin, oxacillin, or cefazolin for methicillin-susceptible staphylococci on native valves; triple therapy (rifampin, gentamicin, plus a beta-lactam or vancomycin) for prosthetic valve staphylococcal infections.
Conclusions:
- Tailored antibiotic regimens are crucial for effective bacterial endocarditis treatment.
- Emerging vancomycin resistance in enterococci necessitates careful monitoring and alternative strategies.
- Vancomycin serves as a penicillin alternative for hypersensitive patients.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management

